Evidence map›Paper›PMID 31019646›Full record

ArticleEplasty2019

Nodular Melanoma in an African American Female.

Vincent Brown, Tom Reisler, Jake Laks

Abstract readCase Reports
In one paragraph

Article in Eplasty, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vincent BrownDepartment of Surgery, The Brody School of Medicine, East Carolina University, Greenville, NC.
Tom ReislerDivision of Plastic and Reconstructive Surgery, Department of Surgery, The Brody School of Medicine, East Carolina University, Greenville, NC.
Jake LaksDepartment of Surgery, The Brody School of Medicine, East Carolina University, Greenville, NC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma incidence is increasing and is associated with the majority of skin cancer-related deaths. Most melanomas have an indolent growth and are difficult to diagnose, attributing to their increased risk of metastatic disease on initial presentation. Nodular melanoma accounts for roughly 15% to 30% of all the melanomas, making it the second most common melanoma. This case describes nodular melanoma, the atypical presentation, the diagnosis, and the treatment. This case is of special interest due to the rarity of the disease and this particular patient's disease presentation and management. Unfortunately, the patient refused further surgery, so definitive treatment was not achieved.

Indexed as

exophytic massmelanomanodular melanomaskin cancerskin lesion

Identifiers

PMID31019646
PMCPMC6467182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.